Immune Checkpoint Inhibitors: Game Changing Cancer Therapy With a Cardiac Cost. What Are the Mechanisms and Unresolved Questions in Cardiotoxicity?

Can J Cardiol. 2018 Aug;34(8):970-971. doi: 10.1016/j.cjca.2018.04.010. Epub 2018 Apr 13.

Authors

Christopher B Johnson¹, Michael Ong²

Affiliations

¹ Division of Cardiology, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: [email protected].
² Division of Medical Oncology, University of Ottawa, Ottawa, Ontario, Canada.

PMID: 29960805
DOI: 10.1016/j.cjca.2018.04.010

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cardiotoxicity
Heart
Heart Diseases*
Humans
Immunotherapy
Neoplasms*